Differential Effects of TcdB1 and TcdB2 in C. difficile disease

TcdB1 和 TcdB2 在艰难梭菌疾病中的不同作用

基本信息

项目摘要

 DESCRIPTION (provided by applicant): Clostridium difficile is a leading cause of hospital-acquired illness in developed countries. Treating C. difficile infection (CDI) is complicated by antibiotic resistance, recurrence (RCDI), and hypervirulence of emerging strains that produce a highly toxic variant of TcdB. TcdB is a major C. difficile virulence factor that contributes to gastrointestinal damage, inflammation, and systemic damage. In these studies experiments will characterize the differences between the historical and milder form of TcdB (TcdB1) and the hypertoxic TcdB2. Published and preliminary data from our group shows that TcdB2 has a broader tropism and is more cytotoxic than TcdB1. In addition, antibodies to TcdB1 do not cross-neutralize TcdB2, suggesting that current vaccines and therapeutic antibodies targeting TcdB may not provide broad protection against multiple strains of C. difficile. The study will examine molecular differences between TcdB1 and TcdB2 to determine how these impact cellular intoxication, antigenicity, and influence RCDI. Aim 1 will characterize the differences in dual-receptor interactions between TcdB1 and TcdB2, assess how this impacts endocytosis, and identify key residues that influence these events. Aim 2 will explore a mechanism through which TcdB2 cloaks neutralizing epitopes which are otherwise exposed in TcdB1. Experiments in aim 3 of this project will determine how the differences in TcdB1 and TcdB2 predispose patients to RCDI. The results from this project will provide the first insights into the differentil effects of TcdB1 and TcdB2 and the impact of TcdB2's heightened toxicity and altered antigenicity on the emergence of hypervirulent strains of C. difficile.
 描述(由申请人提供):艰难梭菌是发达国家医院获得性疾病的主要原因。艰难梭菌感染 (CDI) 的治疗因抗生素耐药性、复发 (RCDI) 以及产生 TcdB 剧毒变体的新兴菌株的高毒力而变得复杂。 TcdB 是艰难梭菌的主要毒力因子,可导致胃肠道损伤、炎症和全身损伤。在这些研究中,实验将描述历史上较温和的 TcdB (TcdB1) 与剧毒 TcdB2 之间的差异。我们小组已发表的初步数据表明,TcdB2 比 TcdB1 具有更广泛的趋向性和更强的细胞毒性。此外,TcdB1 抗体不会交叉中和 TcdB2,这表明当前针对 TcdB 的疫苗和治疗性抗体可能无法针对多种艰难梭菌菌株提供广泛的保护。该研究将检查 TcdB1 和 TcdB2 之间的分子差异,以确定它们如何影响细胞中毒、抗原性和 RCDI。目标 1 将描述差异的特征 TcdB1 和 TcdB2 之间的双受体相互作用,评估其如何影响内吞作用,并确定影响这些事件的关键残基。目标 2 将探索 TcdB2 隐藏中和表位的机制,否则这些表位会在 TcdB1 中暴露。该项目目标 3 的实验将确定 TcdB1 和 TcdB2 的差异如何使患者容易患 RCDI。该项目的结果将首次深入了解 TcdB1 和 TcdB2 的不同作用,以及 TcdB2 的毒性增强和抗原性改变对艰难梭菌高毒力菌株出现的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jimmy D. Ballard其他文献

A toxin contest
一场毒素竞赛
  • DOI:
    10.1038/467665a
  • 发表时间:
    2010-10-06
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Jimmy D. Ballard
  • 通讯作者:
    Jimmy D. Ballard
CSPG4-dependent cytotoxicity for emC. difficile/em TcdB is influenced by extracellular calcium and chondroitin sulfate
艰难梭菌 TcdB 对 emC 的 CSPG4 依赖性细胞毒性受细胞外钙和硫酸软骨素的影响
  • DOI:
    10.1128/msphere.00094-24
  • 发表时间:
    2024-03-12
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    D. Annie Doyle;Paul L. DeAngelis;Jimmy D. Ballard;Sarah E. F. D'Orazio
  • 通讯作者:
    Sarah E. F. D'Orazio
Critical intermediate steps in <em>Clostridium sordellii</em> lethal toxin-induced apoptosis
  • DOI:
    10.1016/j.bbrc.2007.09.073
  • 发表时间:
    2007-11-30
  • 期刊:
  • 影响因子:
  • 作者:
    Daniel E. Voth;Jimmy D. Ballard
  • 通讯作者:
    Jimmy D. Ballard
A toxin contest
一场毒素竞赛
  • DOI:
    10.1038/467665a
  • 发表时间:
    2010-10-06
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Jimmy D. Ballard
  • 通讯作者:
    Jimmy D. Ballard

Jimmy D. Ballard的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jimmy D. Ballard', 18)}}的其他基金

Oklahoma C. difficile U19 Challenge Core
俄克拉荷马州艰难梭菌 U19 挑战核心
  • 批准号:
    10625174
  • 财政年份:
    2023
  • 资助金额:
    $ 18.5万
  • 项目类别:
Enhancing C. difficile vaccination in the context of TcdB-mediated immunosuppression.
在 TcdB 介导的免疫抑制背景下加强艰难梭菌疫苗接种。
  • 批准号:
    10625175
  • 财政年份:
    2023
  • 资助金额:
    $ 18.5万
  • 项目类别:
Oklahoma CMP&I Administrative Core
俄克拉荷马州 CMP
  • 批准号:
    10554352
  • 财政年份:
    2020
  • 资助金额:
    $ 18.5万
  • 项目类别:
Oklahoma Center for Microbial Pathogenesis and Immunity
俄克拉荷马州微生物发病机制和免疫中心
  • 批准号:
    10341201
  • 财政年份:
    2020
  • 资助金额:
    $ 18.5万
  • 项目类别:
Oklahoma Center for Microbial Pathogenesis and Immunity
俄克拉荷马州微生物发病机制和免疫中心
  • 批准号:
    10554351
  • 财政年份:
    2020
  • 资助金额:
    $ 18.5万
  • 项目类别:
Oklahoma CMP&I Administrative Core
俄克拉荷马州 CMP
  • 批准号:
    10341202
  • 财政年份:
    2020
  • 资助金额:
    $ 18.5万
  • 项目类别:
Differential Effects of TcdB1 and TcdB2 in C. difficile disease
TcdB1 和 TcdB2 在艰难梭菌疾病中的不同作用
  • 批准号:
    10094178
  • 财政年份:
    2015
  • 资助金额:
    $ 18.5万
  • 项目类别:
Differential Effects of TcdB1 and TcdB2 in C. difficile disease
TcdB1 和 TcdB2 在艰难梭菌疾病中的不同作用
  • 批准号:
    10331732
  • 财政年份:
    2015
  • 资助金额:
    $ 18.5万
  • 项目类别:
Differential Effects of TcdB1 and TcdB2 in C. difficile disease
TcdB1 和 TcdB2 在艰难梭菌疾病中的不同作用
  • 批准号:
    10548849
  • 财政年份:
    2015
  • 资助金额:
    $ 18.5万
  • 项目类别:
Edema Toxin Suppression of Immune Responses During Anthrax Disease
炭疽病期间水肿毒素抑制免疫反应
  • 批准号:
    7695606
  • 财政年份:
    2009
  • 资助金额:
    $ 18.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 18.5万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.5万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 18.5万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 18.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 18.5万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 18.5万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 18.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了